Sensorion to Lead Symposium on Hearing Loss Treatment
Sensorion will lead a symposium at the 36th World Congress of Audiology in Paris called “Are we at the Dawn of a Hearing Loss Revolution?”
Read MoreSensorion will lead a symposium at the 36th World Congress of Audiology in Paris called “Are we at the Dawn of a Hearing Loss Revolution?”
Read MoreChildren with developmental disabilities—1 in 6 children in the United States—are less likely to access a gold-standard hearing assessment in the first three months of hearing care, a recent paper reported.
Read MoreWhile frequency lowering to accommodate cochlear dead zones is relatively common, frequency raising is not—so far.
Read MoreCAA Conference 2024 will offer two pre-conference workshops and a program full of varied and relevant talks by leaders in the field.
Read MoreThe clinical innovation lab is improving the use of 3D printing for custom pediatric hearing aid earmolds to significantly improve efficiency in patient care.
Read MoreMany organizations find themselves violating HIPAA, not due to inadequate cybersecurity measures, but because of the human factor.
Read MoreThe PROHEAR study is a placebo-controlled Phase 2a study investigating the otoprotective efficacy of ACOU085 in patients with testicular cancer undergoing cisplatin-based chemotherapy.
Read MoreResearchers successfully restored hearing in adult mice with inherited hearing loss by using gene editing to shut down a damaged copy of the MIR96 gene.
Read MoreThe Ear Science Institute Australia’s project on sensorineural hearing loss treatment will receive research support from MedChem Australia.
Read MorePhonak introduces the Audéo Sphere Infinio, a hearing aid with a real-time AI chip designed to enhance speech clarity in noisy environments, as part of its new Infinio portfolio.
Read MoreDrummer Mark Schulman’s hearing loss due to prolonged exposure to loud music led him to shift careers. His new hearing aids allow him to experience improved hearing in his personal and professional life.
Read MoreSound Pharmaceuticals has completed a Phase 3 clinical trial for SPI-1005, a novel anti-inflammatory treatment for Meniere’s Disease, showing potential improvements in hearing loss and tinnitus.
Read MoreThe goal is to attract at least 10,000 participants to explore how hearing training affects skills like speech comprehension and sound localization.
Read MoreFor the third consecutive year, Starkey was named a top workplace, with a spot on the list of the Top 200 Workplaces in Minnesota.
Read MoreThe hearing aid market is projected to expand by $3.17 billion by 2028, propelled by innovative technologies and increased demand.
Read More